Search - Archive ouverte HAL Access content directly

Filter your results

23 Results
Structure: Internal structure identifier : 456709

Les points chauds de l’actualité en 2017. Une sélection du comité de rédaction du Bulletin du Cancer

Stéphane Vignot , Thierry André , Christophe Caux , Carole Bouleuc , Serge Evrard et al.
Bulletin du Cancer, 2018, 105 (1), pp.6 - 14. ⟨10.1016/j.bulcan.2017.11.006⟩
Journal articles hal-01712424v1
Image document

Clinical practice guidelines for BRCA1 and BRCA2 genetic testing

Pascal Pujol , Massimo Barberis , Philp Beer , Eitan Friedman , Josep M Piulats et al.
European Journal of Cancer, 2021, 146, pp.30-47. ⟨10.1016/j.ejca.2020.12.023⟩
Journal articles hal-03225540v1

Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting

Jean-Alexandre Long , Jean-Christophe Bernhard , Pierre Bigot , Cécilia Lanchon , Philippe Paparel et al.
World Journal of Urology, 2017, 35 (4), pp.649 - 656. ⟨10.1007/s00345-016-1913-4⟩
Journal articles hal-01792768v1

Bamlanivimab + Etesevimab Therapy Induces SARS-CoV-2 Immune Escape Mutations and Secondary Clinical Deterioration in COVID-19 Patients with B-cell Malignancies

F. Pommeret , J. Colomba , C. Bigenwald , A. Laparra , S. Bockel et al.
Annals of Oncology, 2021, 32 (11), pp.1445--1447. ⟨10.1016/j.annonc.2021.07.015⟩
Journal articles hal-03793520v1

Estimation of Unbound Carboplatin Clearance From Total Plasma Concentrations as a Means of Facilitating Therapeutic Drug Monitoring

Sotheara Moeung , Christine Chevreau , Vianney Poinsignon , Jérôme Guitton , Bénédicte Lelièvre et al.
Therapeutic Drug Monitoring, 2019, 41 (1), pp.66-74. ⟨10.1097/FTD.0000000000000569⟩
Journal articles hal-02481351v1

Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomes

Pierre Bigot , Jean-François Hétet , Jean-Christophe Bernhard , Tarek Fardoun , François Audenet et al.
Clinical Genitourinary Cancer, 2014, 12 (1), pp.e19--27. ⟨10.1016/j.clgc.2013.09.004⟩
Journal articles hal-01064296v1

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Bertrand Routy , Emmanuelle Le Chatelier , Lisa Derosa , Connie Duong , Maryam Tidjani Alou et al.
Science, 2018, 359 (6371), pp.91-97. ⟨10.1126/science.aan3706⟩
Journal articles hal-02126484v1

Prospective Evaluation of the Impact of Antiangiogenic Treatment on Cognitive Functions in Metastatic Renal Cancer

Florence Joly , Natacha Heutte , Brigitte Duclos , Sabine Noal , Isabelle Léger-Hardy et al.
European Urology Focus, 2016, 2 (6), pp.642 - 649. ⟨10.1016/j.euf.2016.04.009⟩
Journal articles hal-01893539v1
Image document

Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer

Anne Chauchereau , Nader Al Nakouzi , Catherine Gaudin , Sylvestre Le Moulec , Daniel Compagno et al.
Experimental Cell Research, 2011, 317 (3), pp.262-275. ⟨10.1016/j.yexcr.2010.10.012⟩
Journal articles hal-03211032v1
Image document

Mutations of the von Hippel–Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma

A Perier , G Fregni , S Wittnebel , S Gad , M Allard et al.
Oncogene, 2011, 30 (23), pp.2622-2632. ⟨10.1038/onc.2010.638⟩
Journal articles inserm-03349262v1

Local recurrence after radical nephrectomy for kidney cancer: management and prediction of outcomes. a multi-institutional study

Philippe Paparel , Pierre Bigot , Xavier Matillon , Karim Bensalah , Laurent Salomon et al.
Journal of Surgical Oncology, 2014, 109 (2), pp.126--131. ⟨10.1002/jso.23473⟩
Journal articles istex hal-01064319v1

MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array

Laurence Albiges , Justine Guegan , Audrey Le Formal , Virginie Verkarre , Nathalie Rioux-Leclercq et al.
Clinical Cancer Research, 2014, 20 (13), pp.3411--3421. ⟨10.1158/1078-0432.CCR-13-2173⟩
Journal articles hal-01064619v1

Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status

Yosra Messai , Sophie Gad , Muhammad Zaeem Noman , Gwenael Le Teuff , Sophie Couve et al.
European Urology, 2016, 70 (4), pp.623-632. ⟨10.1016/j.eururo.2015.11.029⟩
Journal articles hal-01255838v1

Sexual Disorders of Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Antiangiogenic Therapies

Angeline Denouel , Natacha Heutte , Bernard Escudier , Jean-Emmanuel Kurtz , Mélanie dos Santos et al.
Clinical Genitourinary Cancer, 2018, 16 (5), pp.369-375.e1. ⟨10.1016/j.clgc.2018.05.013⟩
Journal articles hal-02280077v1

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

A. Mejean , A. Ravaud , S. Thezenas , S. Colas , J. -B. Beauval et al.
New England Journal of Medicine, 2018, 379 (5), pp.417-427. ⟨10.1056/NEJMoa1803675⟩
Journal articles hal-02143533v1
Image document

Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literature

Gwenaëlle Gravis , François Audenet , Jacques Irani , Marc-Olivier Timsit , Philippe Barthélémy et al.
Cancer Treatment Reviews, 2017, 55, pp.211-217. ⟨10.1016/j.ctrv.2016.09.008⟩
Journal articles hal-01632557v1

Néphrectomie partielle vs ablation percutanée dans le traitement de tumeurs rénales en indication impérative

J. Long , J. Bernhard , P. Bigot , C. Lanchon , P. Paparel et al.
Progrès en Urologie, 2016, 26 (13), pp.693-694. ⟨10.1016/j.purol.2016.07.050⟩
Journal articles hal-02279563v1

The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma

Helena Polena , Julie Creuzet , Maeva Dufies , Adama Sidibé , Abir Khalil-Mgharbel et al.
British Journal of Cancer, 2018, 118 (9), pp.1179-1188. ⟨10.1038/s41416-018-0054-5⟩
Journal articles hal-02005080v1

Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor Group

Marine Sroussi , Reza Elaidi , Aude Fléchon , Marianne Lorcet , Delphine Borchiellini et al.
Clinical Genitourinary Cancer, 2019, ⟨10.1016/j.clgc.2019.11.014⟩
Journal articles hal-02556645v1

Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?

Pierre Bigot , Tarek Fardoun , Jean Christophe Bernhard , Evanguelos Xylinas , Julien Berger et al.
World Journal of Urology, 2014, 32 (1), pp.109--114. ⟨10.1007/s00345-013-1088-1⟩
Journal articles hal-01064633v1

NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab

L. Carril Ajuria , M. Naigeon , C. Dalban , A. Desnoyer , N. Rioux-Leclercq et al.
Annals of Oncology, 2021, 32, pp.S704-S705. ⟨10.1016/j.annonc.2021.08.083⟩
Journal articles hal-03440287v1

Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group

Emmanuel Meyer , David Pasquier , Guillemette Bernadou , Gilles Calais , Pierre Maroun et al.
European Journal of Cancer, 2018, 98, pp.38-47. ⟨10.1016/j.ejca.2018.04.008⟩
Journal articles hal-02021697v1

Isolation and characterization of renal cancer stem cells from patient-derived xenografts

Meriem Hasmim , Stefania Bruno , Sandy Azzi , Cindy Gallerne , Julien Giron Michel et al.
Oncotarget, 2016, 7 (13), ⟨10.18632/oncotarget.6266⟩
Journal articles hal-02069078v1